GlassScriptPhysician profile
Almas Khan
NPI 1093190738
$1,590.08
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $20.39 · 2021: $18.30 · 2022: $408 · 2023: $454 · 2024: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Food and Beverage | $173.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $457.38 | 2019-2024 | Air Optix |
| Johnson & Johnson Vision Care, INC. | $375.13 | 2019-2024 | Acuvue |
| Coopervision INC. | $372.35 | 2022-2024 | Clariti Contact Lens |
| Nuvasive, INC. | $154.18 | 2023 | Pulse, Tlif, Xlif |
| Topcon Healthcare, INC. | $79.26 | 2022 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Celularity INC. | $47.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.39 | 2020 | |
| Allergan, INC. | $18.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Almas Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.